University of Brescia
About University of Brescia
The University of Brescia is an Italian public research university located in Brescia, Italy. It was founded in 1982 and is branched in 4 Faculties. The University of Brescia was officially established in 1982 with three Schools: Medicine and Surgery, Engineering, Economics and Business.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
European Organisation for Research and Treatment of Cancer - EORTC
2
Thomas Jefferson University
2
ANRS, Emerging Infectious Diseases
1
Actelion
1
Alector Inc.
1
Antisoma Research
1
CSL Behring
1
ETOP IBCSG Partners Foundation
1
Gilead Sciences
1
IRCCS Eugenio Medea
1
KU Leuven
1
Clinical Trials at University of Brescia
During the past decade, University of Brescia conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 2 clinical trials were completed, i.e. on
average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer
1993-05-01
2010-08-01
Completed
452
Pelvic Drains After Radical Hysterectomy in Treating Patients With Uterine, Cervical, or Vaginal Cancer
1998-02-01
Completed
214
Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
2004-06-01
Unknown status
279
Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study
2007-06-01
Unknown status
420
Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis
2010-05-01
2017-08-01
Completed
704
Study of Darunavir/r + Tenofovir/Emtricitabine vs. Darunavir/r + Raltegravir in HIV-infected Antiretroviral naïve Subjects
2010-08-01
2013-10-01
Completed
800
Searching for Explanations for Cryptogenic Stroke in the Young: Revealing the Etiology, Triggers, and Outcome
2013-11-01
2031-12-01
Recruiting
1,200
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "University of Brescia" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials, followed by "Thomas Jefferson University" with 2 trials
sponsored, "ANRS, Emerging Infectious Diseases" with 1 trials sponsored, "Actelion" with 1 trials sponsored and "Alector Inc."
with 1 trials sponsored. Other sponsors include 8 different institutions and
companies that sponsored additional 18 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "University of Brescia"
#1 collaborator was "Università degli Studi di Brescia" with 3 trials as a collaborator, "Federico II University" with 2 trials as a collaborator, "Academy of Finland" with 1 trials as a collaborator, "Albany Medical College" with 1 trials as a collaborator and "American University of Beirut Medical Center" with 1 trials as a collaborator. Other collaborators include 38 different institutions and companies that were
collaborators in the rest 48 trials.
Clinical Trials Conditions at University of Brescia
According to Clinical.Site data, the most researched conditions in "University of Brescia" are
"Pregnancy Related" (2 trials), "Preterm Birth" (2 trials), "Anxiety" (1 trials), "Brain Infarction" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "University of Brescia" in a lesser frequency.
Clinical Trials Intervention Types at University of Brescia
Most popular intervention types in "University of Brescia" are "Drug" (9 trials), "Other" (4 trials), "Procedure" (4 trials), "Behavioral" (1 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "3rd ARV agent" (1 trials), "ABC/3TC" (1 trials), "ABC/3TC Placebo" (1 trials) and "AL001" (1 trials). Other intervention names were less common.
Clinical Trials Genders at University of Brescia
The vast majority of trials in "University of Brescia" are
15 trials for "All" genders and 5 trials for "Female" genders.
Clinical Trials Status at University of Brescia
Currently, there are NaN active trials in "University of Brescia".
undefined are not yet recruiting,
5 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in University of Brescia,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in University of Brescia, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 4 trials that are defined as “Not Applicable".
Departments of University of Brescia
University of Brescia has several departments that took part in Clinical trials: "Chair of Haematology, Bone Marrow Transplant Unit" - 4 trials, "Università di Brescia; Dipartimento di Dermatologia" - 2 trials
Departments List
Name
City
Trials